Executive Director

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity:

As an Executive Director and Head of Research Computational Biology within our Biology Function, the individual will oversee the scientific and strategic direction of systems biology research and preclinical computational biology initiatives. The individual will lead a team of computational biologists and bioinformaticians focused on acquisition, organization, and analysis of large multi-omics data sets, using both public and proprietary data sources, that will help inform treatment strategies and guide patient stratification for a growing pipeline of RAS(ON) and targeted oncology therapeutics. We are looking for an experienced leader with strong interpersonal skills and an ability to lead a strong and diverse computational biology team. Key aspects of the role include:

• Strategic vision and leadership: Develop and implement a long-term strategy for research systems biology and bioinformatic activities to support a growing pipeline of RAS(ON) and novel targeted inhibitors. Lead and supervise a team of experienced computational biologists and bioinformaticians to generate, organize, and interpret large data sets to inform therapeutic and combination strategies for patients with cancer.

• Cross-functional collaboration across research, translational, development and medical affairs groups: Work across functions to support advancement of programs from early discovery into clinical development using biological insights derived from computational approaches. Additionally, leverage clinical data from RVMD investigational agents to generate proprietary insights into RAS mutant tumor biology and RVMD RAS(ON) inhibitor mechanisms of action.

• Technical leadership and innovation: Lead a team analyzing large, high-dimensional datasets. Work with colleagues in Information Sciences and Information Systems to oversee data integration, analysis and visualization using cloud-based platforms (AWS, Azure, GCP). Direct the development and application of cutting-edge statistical analysis, AI/ML methods, generative AI models, and MLOps principles to elucidate findings and generate new insights related to biomarker discovery, drug target identification, and predictive modeling. Establish and implement modern workflow management systems (Snakemake, Nextflow) and reproducible research practices.